Search results

Saughter and May advised Reckitt Benckiser Group plc on the establishment of an EMTN programme and subsequent issuances Saughter and May advised Reckitt Benckiser Group plc on the establishment of an EMTN programme and subsequent issuances Saughter and May is advising Aviva on the acquisition of AIG's UK protection business Saughter and May is advising Aviva on the acquisition of AIG's UK protection business Saughter and May advised MTR Corporation Limited on its issuance of HKD150 million 4.6% Fixed Rate Notes due 14 September 2025 Saughter and May, Hong Kong, advised MTR Corporation Limited on its issuance of HKD150 million 4.6% Fixed Rate Notes due 14 September 2025 (the Notes) Saughter and May advised MTR Corporation Limited on its issuance of HKD150 million 4.72% Fixed Rate Notes due 19 September 2025 Saughter and May, Hong Kong, advised MTR Corporation Limited on its issuance of HKD150 million 4.72% Fixed Rate Notes due 19 September 2025 Saughter and May advised MTR on the KWU Tung station and Tuen Mun south extension projects Saughter and May advised MTR on the KWU Tung station and Tuen Mun south extension projects Saughter and May advised MTR Corporation Limited on its issuance of HKD900 million fixed rate notes Saughter and May advised MTR Corporation Limited on its issuance of HKD900 million fixed rate notes Saughter and May advised CMB International Capital on the USD51 million issuance and sale of shares of Shandong Fengxiang Co., Ltd Saughter and May, Hong Kong, advised CMB International Capital on the USD51 million issuance and sale of shares of Shandong Fengxiang Co., Ltd Saughter and May are advising DMG Media on its proposed joint venture with News UK Saughter and May are advising DMG Media on its proposed joint venture with News UK Saughter and May is advising The Restaurant Group plc on its recommended cash acquisition by Apollo Saughter and May is advising The Restaurant Group plc on its recommended cash acquisition by Apollo Saughter and May is advising Orchard Therapeutics on its recommended cash acquisition by Kyowa Kirin Saughter and May is advising Orchard Therapeutics on its recommended cash acquisition by Kyowa Kirin